You are here

A high resolution and high DQE detector optimized for mammography using single shot bi directional tri contrast imaging

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 4R44EB021125-02
Agency Tracking Number: R44EB021125
Amount: $1,499,904.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NIBIB
Solicitation Number: PA14-071
Timeline
Solicitation Year: 2014
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-09-05
Award End Date (Contract End Date): 2019-04-30
Small Business Information
5750 IMHOFF DR STE I, Concord, CA, 94520-5348
DUNS: 079183051
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 WENBING YUN
 (925) 947-1469
 wyun@sigray.com
Business Contact
 SYLVIA LEWIS
Phone: (925) 207-0925
Email: slewis@sigray.com
Research Institution
N/A
Abstract
DESCRIPTION provided by applicant X ray tricontrast imaging provides three different modes of contrast absorption contrast the mechanism behind how conventional medical X ray imaging equipment images phase contrast which provides up to X more contrast than absorption based contrast for soft tissue and scatter contrast which provides information of features at dimensions smaller than the resolution of absorption and phase contrast Access to all three contrast modes is widely considered one of the most exciting developments in modern X ray physics and has significant potential to change the face of biomedical imaging for early detection of cancer osteoarthritis and other soft tissue diseases The recent development of Talbot Lau interferometry a grating based technique that uses three gratings to achieve tricontrast imaging has high potential to achieve tricontrast imaging in clinical use However there are several major limitations stemming from the use of two out of the three gratings These two gratings are not entirely necessary and the removal of the gratings would still allow the technique to work as long as substantial innovation is made to the source and to the detector We propose to develop a high detective quantum efficiency DQE microstructured detector with good resolution to enable clinical Talbot interferometers without need of one of the two problematic gratings The other grating may be removed by innovation on the source for which we have also devised a proposal that has previously been submitted to the NIH and is awaiting a final funding decision it received an outstanding impact score of The proposed Phase I month project is a proof of principle demonstration that the microstructured detector can be manufactured and would provide high detective quantum efficiency and the proposed Phase II month project would produce working prototypes of the detector PUBLIC HEALTH RELEVANCE This project proposes to develop a high detective quantum efficiency DQE detector that is optimized to enable clinical imaging with tricontrast imaging that provides three different modes of X ray contrast absorption imaging currently used in medical X ray imaging equipment phase contrast which provides up to X more contrast than current X ray imaging techniques for soft tissue and scatter contrast which provides information of features at dimensions smaller than the resolution of absorption and phase contrast Neither phase contrast nor scatter contrast are currently available by conventional medical X ray imaging Bringing tricontrast capabilities to hospitals and clinics will have a dramatic impact on diagnosis and treatment of breast cancer and osteoarthritis as it has the potential to detect early stage soft tissue disease progression

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government